Perioperative immunotherapy: the main clinical treatment for resectable non-small cell lung cancer

Zhijun Yuan1, Mengyuan Yang2,3, Xian Zhong2,3

  • 1Department of Radiation Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.

Medcomm
|February 29, 2024
PubMed

Related Concept Videos